Guillermo Garcia-Manero

194PUBLICATIONS
534CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsRegenerative medicine (incl. stem cells)Gene and molecular therapyHaematological tumoursAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (194)

|Aug 13, 2026
Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia.

|Jul 13, 2026
Magrolimab Plus Azacitidine Versus Placebo Plus Azacitidine in Patients With Untreated Higher-Risk Myelodysplastic Syndromes: The Phase III ENHANCE Study.

|Jul 13, 2026
The novel hypomethylating agent NTX-301 reprograms epigenetic and Hippo signaling pathways and exhibits pre-clinical activity in venetoclax-resistant and TP53-mutant AML.

|Jul 04, 2026
Myelodysplastic Syndromes: 2026 Update on Diagnosis, Risk-Stratification and Management.

|Jun 22, 2026
Investigational clinical trial agents versus conventional second salvage therapies in patients with relapsed/refractory acute myeloid leukemia.

|Jun 11, 2026
All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE).

Pageof 33

Frequent Collaborators

109 joint publications

Tapan M Kadia

107 joint publications

Courtney DiNardo

104 joint publications

Navel G Daver

97 joint publications

Hagop M Kantarjian